Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1995-4-27
|
pubmed:language |
nor
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0029-2001
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
20
|
pubmed:volume |
115
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
582-3
|
pubmed:dateRevised |
2008-7-16
|
pubmed:meshHeading |
pubmed-meshheading:7900108-Cost-Benefit Analysis,
pubmed-meshheading:7900108-Ethics, Medical,
pubmed-meshheading:7900108-Humans,
pubmed-meshheading:7900108-Infant, Newborn,
pubmed-meshheading:7900108-Mass Screening,
pubmed-meshheading:7900108-Metabolism, Inborn Errors,
pubmed-meshheading:7900108-Norway
|
pubmed:year |
1995
|
pubmed:articleTitle |
[Metabolic diseases--screening of newborn infants].
|
pubmed:affiliation |
Barneklinikken Haukeland Sykehus, Bergen.
|
pubmed:publicationType |
Journal Article
|